Jefferies Group Lowers ARIAD Pharmaceuticals, Inc. (ARIA) to Hold
Sports Perspectives | January 17, 2017
Jefferies Group downgraded shares of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) from a buy rating to a hold rating in a report released on Tuesday morning. Jefferies Group currently has $24.00 target price on the pharmaceutical company’s stock, up from their previous target price of $11.00.